PROGRAMS ON DEMAND
CUA Members: Log in to access printable versions and to download the tools directly to your preferred device.
QUICK LINKS:
P. Black, A. Loblaw, N. Fallah-Rad, E. Kassouf, M. Keyes, N. Basappa, A. Swaminath
CUA Highlights of ASCO 2022
CUAJ June 2022: A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer
N. Fleshner, P. Nguyen, C. Plummer
Clinical factors/treatment decisions/localized prostate cancer
B. Shayegan, F. Pouliot, K. Zukotynski, S. Fanti
PSMA PET/CT Beyond the Images: The Imager’s and Clinician’s Perspective
M. Kolinsky & F. Vera-Badillo
Case Studies in Prostate Cancer: Patient Pathways for Genetic Testing and Treatment
S. Gupta
Evolving Treatment Paradigms in Advanced Urothelial Carcinoma
O. Traxer & H. Razvi
Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary Stones
J. de Bono
CUA Speaker Tour: PARP Inhibitors/DNA Damage Repair
Canadian Bladder Cancer Forum 2022
S. Mottard, L. Lavallée, D. Kendler
CUA Q & A Series: Bone Health Management in Prostate Cancer
The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.
For comments or information, email Corporate.office@cua.org